Grants
NIH R21, R03
DUE DATES: Cycle 3: October 16, 2019 by 5 PM of local organization time Cycle 1: February 16, 2020 by 5 PM of local organization time Cycle 2: June 16, 2020 by 5 PM of local organization time Biobehavioral and Technological Interventions to Attenua...
June 16|Recurring Event (See all)One event on February 16, 2020 at 12:00 am
One event on June 16, 2020 at 12:00 am
One event on October 16, 2020 at 12:00 am
Cycle 1: Alzheimer’s Drug Discovery Foundation
LOI Due Dates: Cycle 1: April 10, 2020 Cycle 2: July 10, 2020 Cycle 3: October 9, 2020 Drug Development Program The goal of this RFP is to develop therapeutics for Alzheimer’s disease and related dementias. This RFP focuses on building preclini...
July 10|Recurring Event (See all)One event on July 10, 2020 at 12:00 am
One event on October 9, 2020 at 12:00 am
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Sponsor: National Institutes of Health (multiple Institutes) LOI Due Date: July 12, 2020, January 10, 2021 Application Due Date: August 11, 2020, February 9, 2021 Award: Application budgets are not limited but must reflect the actual needs of the pr...
July 12BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3)
Sponsor: National Institutes of Health LOI Due Dates: May 23, 2020, September 21, 2020 Application Deadlines: June 22, 2020, October 21, 2020 Award: The NIH anticipates providing $10M per year to fund an estimated 5 to 7 awards. Application budgets...
September 21AES Research and Training Workshops
Sponsor: American Epilepsy Society Due Dates: Cycle 1: May 4, 2020 Cycle 2: September 23, 202o Award: AES welcomes applications for funding to support scientific conferences and workshops focused on epilepsy research and training. Applications for ...
September 23AES Seed Grant Program
Sponsor: American Epilepsy Society Due Dates: Cycle 1: May 4, 2020 Cycle 2: September 28, 2020 Award: The AES Seed Grant Program provides support to established investigators to pursue new and innovative directions in epilepsy research, bring new r...
September 28Broad PCORI Funding Announcements
Sponsor: Patient-Centered Outcomes Research Institute LOI Due Date: September 29, 2020 at 5pm ET Application Due Date: January 12, 2021 at 5pm ET Award: The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patie...
September 29Cycle 1: Alzheimer’s Drug Discovery Foundation
LOI Due Dates: Cycle 1: April 10, 2020 Cycle 2: July 10, 2020 Cycle 3: October 9, 2020 Drug Development Program The goal of this RFP is to develop therapeutics for Alzheimer’s disease and related dementias. This RFP focuses on building preclini...
October 9|Recurring Event (See all)One event on July 10, 2020 at 12:00 am
One event on October 9, 2020 at 12:00 am
NIH R21, R03
DUE DATES: Cycle 3: October 16, 2019 by 5 PM of local organization time Cycle 1: February 16, 2020 by 5 PM of local organization time Cycle 2: June 16, 2020 by 5 PM of local organization time Biobehavioral and Technological Interventions to Attenua...
October 16|Recurring Event (See all)One event on February 16, 2020 at 12:00 am
One event on June 16, 2020 at 12:00 am
One event on October 16, 2020 at 12:00 am
ANGEL (Advanced Neurotherapeutic Grant of Excellence) Award
Sponsor: International Rett Syndrome Foundation (IRSF) Due Date: Applications accepted on a rolling basis Award: Up to $600,000 over two years. Grant awards must be comprised of very specific programs that are focused on pre-clinical drug discovery a...
December 31Rolling Basis: Alzheimer’s Drug Discovery Foundation
PROPOSALS ACCEPTED ON A ROLLING BASIS ADDF/NIH Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities. Conference Funding Supports scientific conferences that are re...
December 31Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Sponsor: National Institutes of Health (multiple Institutes) LOI Due Date: July 12, 2020, January 10, 2021 Application Due Date: August 11, 2020, February 9, 2021 Award: Application budgets are not limited but must reflect the actual needs of the pr...
January 10, 2021